| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-12 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-11 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |